معرفی
Dr. Gabriela Spilberg is an Assistant Professor of Radiology and Biomedical Imaging at the Yale School of Medicine, specializing in nuclear medicine and theranostics. She serves as Director of Theranostics and Clinical Trials in the Radiology and Biomedical Imaging Department, focusing on gastrointestinal cancers, particularly neuroendocrine tumors. Her clinical roles include patient care at Smilow Cancer Hospital and Yale Cancer Center, and she co-directs clinical trials in nuclear medicine.
- Education: MD from Universidade Federal do Rio de Janeiro (Brazil)
- Fellowships: Neuroradiology, Interventional Radiology, Emergency Radiology, Cardiovascular Imaging, PET/CT Cancer Imaging
- Residency: Harvard Joint Program in Nuclear Medicine at Brigham and Women’s Hospital
Research interests include molecular imaging for precision oncology, theranostic applications in cancer treatment, and advanced imaging modalities like PET/CT. She has contributed to studies on interim PET in lymphoma therapy, radiology report impacts on patient care, and neurointerventional techniques.
Dr. Spilberg’s work bridges clinical practice and research, emphasizing translational approaches to improve diagnostic accuracy and targeted therapies. She actively participates in clinical trials and has been featured in podcasts discussing theranostics for prostate and GI cancers.
Labs/Teams: Section of Nuclear Medicine, Yale Cancer Center, and collaborative groups in gastrointestinal oncology and theranostics.
